Metraipolis › archive › dc_ee6af61735fe

Study protocol: Effectiveness of the maternal RSVpreF vaccine by virus type — Europe PMC PMID:41502539

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41502539
DOI
10.12688/wellcomeopenres.24371.1
License (as archived)
solo-consultazione
Archived
2026-11-07T21:52:25.342Z
SHA-256 of the archived text
1d7c252e0cdee87dd47d4cc82deda8182b85fa658b53702d2182ca4642304d60
Stable URL of this page
https://metraipolis.com/documento/dc_ee6af61735fe

How to cite

Study protocol: Effectiveness of the maternal RSVpreF vaccine by virus type — Europe PMC PMID:41502539 — Europe PMC (en), https://europepmc.org/article/MED/41502539 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_ee6af61735fe (Metraipolis archive dc_ee6af61735fe, sha256 1d7c252e0cdee87dd47d4cc82deda8182b85fa658b53702d2182ca4642304d60)
BibTeX
@misc{dcee6af61735fe,
  title = {Study protocol: Effectiveness of the maternal RSVpreF vaccine by virus type — Europe PMC PMID:41502539},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41502539},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_ee6af61735fe; sha256 1d7c252e0cdee87dd47d4cc82deda8182b85fa658b53702d2182ca4642304d60},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41502539. Agents can read the archived copy with the MCP tool read_document.